Company Information

SHUKRA PHARMACEUTICALS LTD.

NSE : NABSE : 524632ISIN CODE : INE551C01028Industry : Pharmaceuticals & DrugsHouse : Private
BSE184.453.6 (+1.99 %)
PREV CLOSE ( ) 180.85
OPEN PRICE ( ) 177.25
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 204305
TODAY'S LOW / HIGH ( )177.25 184.45
52 WK LOW / HIGH ( ) 30.79184.45
NSE
This Company is not listed in NSE
Managing DirectorDakshesh Rameshchandra Shah
Company SecretaryArpita Kabraa
Executive DirectorPayal Mehta
Non Executive Independent DirectorBhoomiben Patel
Sonal Deepalbhai Gandhi
Sarjeevan Singh
Jitendra Shah
Pinki Nirmal Sagar
Whole Time DirectorSanskruti Patel
Dhruvin Shah
Anar Jayesh Patel
Incorporation Year : 04-03 1993

Registered Office :

Address : 3rd Floor, Veer House,Opp Wiaa Office ,Judges Bunglow Road Bodakdev Ahmedabad,
Gujarat-380054 .

Phone : 079-27498515

Industry : Pharmaceuticals & Drugs

Listing : BSE

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.